Literature DB >> 17470328

The US Food and Drug Administration: a dysfunctional agency in need of major reforms.

Steven E Nissen.   

Abstract

Mesh:

Year:  2007        PMID: 17470328     DOI: 10.1007/bf02938344

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


× No keyword cloud information.
  7 in total

1.  Cerivastatin and reports of fatal rhabdomyolysis.

Authors:  Judy A Staffa; Jennie Chang; Lanh Green
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

2.  The need for regulation of dietary supplements--lessons from ephedra.

Authors:  Phil B Fontanarosa; Drummond Rennie; Catherine D DeAngelis
Journal:  JAMA       Date:  2003-03-10       Impact factor: 56.272

3.  Medical research has 'black hole': negative results often fail to get published in journals; some blame drug industry.

Authors:  Scott Hensley; Leila Abboud
Journal:  Wall St J (East Ed)       Date:  2004-06-04

4.  The importance of negative and neutral clinical trials.

Authors:  Eldon R Smith
Journal:  Can J Cardiol       Date:  2004-10       Impact factor: 5.223

5.  Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors.

Authors:  Catherine D Deangelis; Jeffrey M Drazen; Frank A Frizelle; Charlotte Haug; John Hoey; Richard Horton; Sheldon Kotzin; Christine Laine; Ana Marusic; A John P M Overbeke; Torben V Schroeder; Hal C Sox; Martin B Van Der Weyden
Journal:  JAMA       Date:  2005-05-23       Impact factor: 56.272

6.  Dangerous deception--hiding the evidence of adverse drug effects.

Authors:  Jerry Avorn
Journal:  N Engl J Med       Date:  2006-11-23       Impact factor: 91.245

7.  Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.

Authors:  Steven E Nissen; Kathy Wolski; Eric J Topol
Journal:  JAMA       Date:  2005-10-20       Impact factor: 56.272

  7 in total
  1 in total

Review 1.  New drugs for type 2 diabetes mellitus: what is their place in therapy?

Authors:  Andrew J Krentz; Mayank B Patel; Clifford J Bailey
Journal:  Drugs       Date:  2008       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.